Loading…
Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma
Micro-Abstract The prognostic significance of sarcopenia (muscle loss) in patients with metastatic urothelial carcinoma (UC) is unclear. Furthermore, its evaluation methods are not entirely standardized. Using several types of computed tomography-based evaluation, we assessed the association of sarc...
Saved in:
Published in: | Clinical genitourinary cancer 2016-06, Vol.14 (3), p.237-243 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803 |
---|---|
cites | cdi_FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803 |
container_end_page | 243 |
container_issue | 3 |
container_start_page | 237 |
container_title | Clinical genitourinary cancer |
container_volume | 14 |
creator | Taguchi, Satoru Akamatsu, Nobuhiko Nakagawa, Tohru Gonoi, Wataru Kanatani, Atsushi Miyazaki, Hideyo Fujimura, Tetsuya Fukuhara, Hiroshi Kume, Haruki Homma, Yukio |
description | Micro-Abstract The prognostic significance of sarcopenia (muscle loss) in patients with metastatic urothelial carcinoma (UC) is unclear. Furthermore, its evaluation methods are not entirely standardized. Using several types of computed tomography-based evaluation, we assessed the association of sarcopenia with survival in patients with metastatic UC. Multivariate analysis showed that sarcopenia was an independent prognostic factor in an evaluation using skeletal muscle index. |
doi_str_mv | 10.1016/j.clgc.2015.07.015 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1792775033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1558767315001883</els_id><sourcerecordid>1792775033</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803</originalsourceid><addsrcrecordid>eNp9kVFrFDEUhQdRbK3-AR8kj77MNplMJimIIEtrF1oU1n0O6c2dNdtssiaZYvHPm2GrDz74EE4I55xwv9s0bxldMMqG890C_BYWHWViQeWiyrPmlF1w1dJBdc_rXQjVykHyk-ZVzjtKe8EkfdmcdAPnchD8tPm1NgniAYMz5PLB-MkUtGSTXdiS8h3J-h49FuPJ7ZTBI1kFiz_JKhND1m4b3OjAhEK-prgNMRcH5MpAiYmM9dzWZC5mft2kWOu8q03L-qMLcW9eNy9G4zO-edKzZnN1-W153d58-bxafrppoZeytL1CC6YO3EPHRyENGLRC9VyMUgk0VlA1IO8RestQcVB3IxUcR2mHkSvKz5r3x95Dij8mzEXvXQb03gSMU9ZMXnRSCsp5tXZHK6SYc8JRH5Lbm_SoGdUzdL3TM3Q9Q9dU6io19O6pf7rbo_0b-UO5Gj4cDVinfHCYdAaHAdC6hFC0je7__R__iYN3oYL39_iIeRenFCo_zXTuNNXree3z1pmglCnF-W99wqmI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792775033</pqid></control><display><type>article</type><title>Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma</title><source>ScienceDirect Freedom Collection</source><creator>Taguchi, Satoru ; Akamatsu, Nobuhiko ; Nakagawa, Tohru ; Gonoi, Wataru ; Kanatani, Atsushi ; Miyazaki, Hideyo ; Fujimura, Tetsuya ; Fukuhara, Hiroshi ; Kume, Haruki ; Homma, Yukio</creator><creatorcontrib>Taguchi, Satoru ; Akamatsu, Nobuhiko ; Nakagawa, Tohru ; Gonoi, Wataru ; Kanatani, Atsushi ; Miyazaki, Hideyo ; Fujimura, Tetsuya ; Fukuhara, Hiroshi ; Kume, Haruki ; Homma, Yukio</creatorcontrib><description>Micro-Abstract The prognostic significance of sarcopenia (muscle loss) in patients with metastatic urothelial carcinoma (UC) is unclear. Furthermore, its evaluation methods are not entirely standardized. Using several types of computed tomography-based evaluation, we assessed the association of sarcopenia with survival in patients with metastatic UC. Multivariate analysis showed that sarcopenia was an independent prognostic factor in an evaluation using skeletal muscle index.</description><identifier>ISSN: 1558-7673</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2015.07.015</identifier><identifier>PMID: 26337653</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Biomarker ; Bladder cancer ; Carcinoma, Transitional Cell - diagnosis ; Carcinoma, Transitional Cell - mortality ; Carcinoma, Transitional Cell - secondary ; Chemotherapy ; Computed tomography ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Male ; Middle Aged ; Multivariate Analysis ; Muscle, Skeletal - pathology ; Prognosis ; Retrospective Studies ; Sarcopenia - diagnosis ; Sarcopenia - mortality ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - mortality ; Urinary Bladder Neoplasms - pathology ; Urology</subject><ispartof>Clinical genitourinary cancer, 2016-06, Vol.14 (3), p.237-243</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803</citedby><cites>FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803</cites><orcidid>0000-0003-4041-7241</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26337653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taguchi, Satoru</creatorcontrib><creatorcontrib>Akamatsu, Nobuhiko</creatorcontrib><creatorcontrib>Nakagawa, Tohru</creatorcontrib><creatorcontrib>Gonoi, Wataru</creatorcontrib><creatorcontrib>Kanatani, Atsushi</creatorcontrib><creatorcontrib>Miyazaki, Hideyo</creatorcontrib><creatorcontrib>Fujimura, Tetsuya</creatorcontrib><creatorcontrib>Fukuhara, Hiroshi</creatorcontrib><creatorcontrib>Kume, Haruki</creatorcontrib><creatorcontrib>Homma, Yukio</creatorcontrib><title>Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><description>Micro-Abstract The prognostic significance of sarcopenia (muscle loss) in patients with metastatic urothelial carcinoma (UC) is unclear. Furthermore, its evaluation methods are not entirely standardized. Using several types of computed tomography-based evaluation, we assessed the association of sarcopenia with survival in patients with metastatic UC. Multivariate analysis showed that sarcopenia was an independent prognostic factor in an evaluation using skeletal muscle index.</description><subject>Aged</subject><subject>Biomarker</subject><subject>Bladder cancer</subject><subject>Carcinoma, Transitional Cell - diagnosis</subject><subject>Carcinoma, Transitional Cell - mortality</subject><subject>Carcinoma, Transitional Cell - secondary</subject><subject>Chemotherapy</subject><subject>Computed tomography</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Muscle, Skeletal - pathology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - mortality</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - mortality</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urology</subject><issn>1558-7673</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kVFrFDEUhQdRbK3-AR8kj77MNplMJimIIEtrF1oU1n0O6c2dNdtssiaZYvHPm2GrDz74EE4I55xwv9s0bxldMMqG890C_BYWHWViQeWiyrPmlF1w1dJBdc_rXQjVykHyk-ZVzjtKe8EkfdmcdAPnchD8tPm1NgniAYMz5PLB-MkUtGSTXdiS8h3J-h49FuPJ7ZTBI1kFiz_JKhND1m4b3OjAhEK-prgNMRcH5MpAiYmM9dzWZC5mft2kWOu8q03L-qMLcW9eNy9G4zO-edKzZnN1-W153d58-bxafrppoZeytL1CC6YO3EPHRyENGLRC9VyMUgk0VlA1IO8RestQcVB3IxUcR2mHkSvKz5r3x95Dij8mzEXvXQb03gSMU9ZMXnRSCsp5tXZHK6SYc8JRH5Lbm_SoGdUzdL3TM3Q9Q9dU6io19O6pf7rbo_0b-UO5Gj4cDVinfHCYdAaHAdC6hFC0je7__R__iYN3oYL39_iIeRenFCo_zXTuNNXree3z1pmglCnF-W99wqmI</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Taguchi, Satoru</creator><creator>Akamatsu, Nobuhiko</creator><creator>Nakagawa, Tohru</creator><creator>Gonoi, Wataru</creator><creator>Kanatani, Atsushi</creator><creator>Miyazaki, Hideyo</creator><creator>Fujimura, Tetsuya</creator><creator>Fukuhara, Hiroshi</creator><creator>Kume, Haruki</creator><creator>Homma, Yukio</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4041-7241</orcidid></search><sort><creationdate>20160601</creationdate><title>Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma</title><author>Taguchi, Satoru ; Akamatsu, Nobuhiko ; Nakagawa, Tohru ; Gonoi, Wataru ; Kanatani, Atsushi ; Miyazaki, Hideyo ; Fujimura, Tetsuya ; Fukuhara, Hiroshi ; Kume, Haruki ; Homma, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Biomarker</topic><topic>Bladder cancer</topic><topic>Carcinoma, Transitional Cell - diagnosis</topic><topic>Carcinoma, Transitional Cell - mortality</topic><topic>Carcinoma, Transitional Cell - secondary</topic><topic>Chemotherapy</topic><topic>Computed tomography</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Muscle, Skeletal - pathology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - mortality</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - mortality</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taguchi, Satoru</creatorcontrib><creatorcontrib>Akamatsu, Nobuhiko</creatorcontrib><creatorcontrib>Nakagawa, Tohru</creatorcontrib><creatorcontrib>Gonoi, Wataru</creatorcontrib><creatorcontrib>Kanatani, Atsushi</creatorcontrib><creatorcontrib>Miyazaki, Hideyo</creatorcontrib><creatorcontrib>Fujimura, Tetsuya</creatorcontrib><creatorcontrib>Fukuhara, Hiroshi</creatorcontrib><creatorcontrib>Kume, Haruki</creatorcontrib><creatorcontrib>Homma, Yukio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taguchi, Satoru</au><au>Akamatsu, Nobuhiko</au><au>Nakagawa, Tohru</au><au>Gonoi, Wataru</au><au>Kanatani, Atsushi</au><au>Miyazaki, Hideyo</au><au>Fujimura, Tetsuya</au><au>Fukuhara, Hiroshi</au><au>Kume, Haruki</au><au>Homma, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>14</volume><issue>3</issue><spage>237</spage><epage>243</epage><pages>237-243</pages><issn>1558-7673</issn><eissn>1938-0682</eissn><abstract>Micro-Abstract The prognostic significance of sarcopenia (muscle loss) in patients with metastatic urothelial carcinoma (UC) is unclear. Furthermore, its evaluation methods are not entirely standardized. Using several types of computed tomography-based evaluation, we assessed the association of sarcopenia with survival in patients with metastatic UC. Multivariate analysis showed that sarcopenia was an independent prognostic factor in an evaluation using skeletal muscle index.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26337653</pmid><doi>10.1016/j.clgc.2015.07.015</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4041-7241</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1558-7673 |
ispartof | Clinical genitourinary cancer, 2016-06, Vol.14 (3), p.237-243 |
issn | 1558-7673 1938-0682 |
language | eng |
recordid | cdi_proquest_miscellaneous_1792775033 |
source | ScienceDirect Freedom Collection |
subjects | Aged Biomarker Bladder cancer Carcinoma, Transitional Cell - diagnosis Carcinoma, Transitional Cell - mortality Carcinoma, Transitional Cell - secondary Chemotherapy Computed tomography Female Hematology, Oncology and Palliative Medicine Humans Kaplan-Meier Estimate Lymphatic Metastasis Male Middle Aged Multivariate Analysis Muscle, Skeletal - pathology Prognosis Retrospective Studies Sarcopenia - diagnosis Sarcopenia - mortality Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - mortality Urinary Bladder Neoplasms - pathology Urology |
title | Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A00%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sarcopenia%20Evaluated%20Using%20the%20Skeletal%20Muscle%20Index%20Is%20a%20Significant%20Prognostic%20Factor%20for%20Metastatic%20Urothelial%20Carcinoma&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Taguchi,%20Satoru&rft.date=2016-06-01&rft.volume=14&rft.issue=3&rft.spage=237&rft.epage=243&rft.pages=237-243&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2015.07.015&rft_dat=%3Cproquest_cross%3E1792775033%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-48edca0164c23f57acaed58435f785ead5086e34ec4d1e83c8bf053ef7d6f3803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1792775033&rft_id=info:pmid/26337653&rfr_iscdi=true |